Ayurveda management in terminally sick patients of hepatocellular carcinoma: A case series
Abstract
Hepatocellular Carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. The traditional system of medicines is gaining momentum with increasing acceptance in the management of various pathologies; HCC is also one among such ones. Still, there is no consensus on the Ayurveda treatment algorithm for hepatocellular cancer. This case series is intended to provide evidence of the efficacy of Ayurveda treatment protocol for patients diagnosed with HCC. The case series presents four diagnosed cases of HCC, who were evaluated through pretreatment and during treatment assessment through laboratory data, patient performance status, Child–Pugh Scale, and the Barcelona clinic’s Liver cancer staging system. The survival outcome, i.e., the time from initiation of Ayurveda medication until death was noted for all the cases. An Ayurveda treatment regimen was prepared from conventional practices and administrated to four cases of advanced HCC. The Ayurveda intervention increased the survival time more than the predicted survival time irrespective of etiology, without the contemporary chemotherapy medications, and patient performance status in all four cases. However, hepatitis B virus-infected patients had less survival time than HCC manifested from alcoholic cirrhosis. These preliminary observations have brought an idea about the positive effects of Ayurveda interventions in terminal HCC patients. Further studies are recommended to prepare the Ayurveda treatment…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.